Skip to content

Released Aug 13, 2026, after the close

10-Q filed Aug 13, 2026, 44 days after period end · 0001789769-26-000057

Q2 2026 · 10-Q
Revenue—
Net Income-$4.42MN/M vs Q2 2025N/M vs Q1 2026
EPS Diluted-$0.65N/M vs Q2 2025N/M vs Q1 2026
Operating Income-$6,162,000N/M
Operating Cash Flowderived-$4,642,000N/M

What the release said

The release

Same quarter

MetricQ2 2026Q2 2025Q2 2024Q2 2023
Net Income-$4.42M-$21.39M-$14.92M-$18.66M
EPS Diluted-$0.65-$3.24-$2.29-$2.87

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR